Childhood autoimmune neuropsychiatric disorders associated with streptococcal infections are a group of disorders characterized by the development of neuropsychiatric symptoms in children that occur against the background of an infection caused by group A streptococci. These disorders, also known by the acronym PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections), include such manifestations as obsessive-compulsive disorders, tics, and behavioral changes. The main cause of these pathologies is considered to be an autoimmune response of the body, in which antigens applied by streptococcal infection affect the cellular structures of the brain, causing neuroinflammatory reactions and disrupting the normal functioning of neural circuits.
History of the disease and interesting historical facts
The first descriptions of symptoms similar to the current manifestations of PANDAS were documented in the early 20th century, but the systematic study and isolation of this syndrome as a separate disease began in 1998, when a group of researchers led by Dr. Suater presented the results of their study indicating a link between streptococcal infection and protracted neuropsychiatric disorders in children. Interestingly, for many years, diseases caused by streptococci were considered exclusively infectious, but on the basis of recent studies, the need to pay serious attention to the possibility of an autoimmune reaction was demonstrated. For example, in 2006, a study was conducted that found that about 30% children with obsessive-compulsive disorders had a history of streptococcal infection. Remarkably, many questions still remain regarding the pathophysiological mechanisms regulating this response.
Epidemiology
Statistics confirm that childhood autoimmune neuropsychiatric disorders associated with streptococcal infections are quite common. According to the results of epidemiological studies, the incidence of PANDAS syndrome among children aged 5 to 18 years ranges from 1% to 3%. At the same time, the incidence of this disorder increases significantly after cases of streptococcal sore throat, especially in epidemic outbreaks. It is important to note that boys are slightly more likely to be affected by this disease than girls, which creates conditions for further study of the gender aspects of the disease. In addition, studies show that about 50% children with PANDAS have a history of previous contact with streptococcal infections, which emphasizes the importance of timely diagnosis and treatment of these infections.
Genetic predisposition to this disease
To date, many genetic factors have been identified that are associated with the development of PANDAS. Studies show that some patients have mutations in genes responsible for the immune response, such as genes encoding components of the complement system. In addition, genetic testing has revealed the presence of polymorphisms in genes associated with inflammatory and autoimmune processes. These data indicate that certain genetic lines may predispose children to the development of neuropsychiatric disorders after infection with streptococci. However, specific markers that could be used to predict or diagnose PANDAS have not yet been identified, so further genetic research is needed.
Risk factors for the development of this disease
Among the key risk factors contributing to the development of PANDAS, two main areas can be distinguished: infectious and non-infectious factors. Infectious factors include:
- Streptococcal infections, in particular, tonsillitis, scarlet fever and other manifestations of streptococcal infection.
- Frequent respiratory infections in children with weakened immune systems.
Non-infectious risk factors include:
- Hereditary predisposition and the presence of autoimmune diseases in the family.
- Neurological disorders and pre-existing psychiatric disorders in the child.
- Psychosocial factors such as stress and trauma.
Understanding risk factors is important for prevention and early detection of possible cases of PANDAS.
Diagnosis of this disease
The diagnosis of PANDAS is based on clinical presentation and history. Key symptoms may include, but are not limited to:
- Obsessive-compulsive disorder (OCD).
- Tic disorders.
- Changes in behavior and irritability.
- Sleep and appetite disturbances.
Laboratory tests may include:
- Determination of the level of antibodies to streptococci (anti-streptolysin O, ASO).
- Tests for inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
Radiological examinations can help rule out other possible pathologies:
- Magnetic resonance imaging (MRI) to assess structural changes in the brain.
Other types of diagnostics include:
- Neuropsychological testing to assess cognitive function.
- Clinical interview with parents and teachers to understand changes in behavior.
It is also important to differentiate from other autoimmune and neurological disorders, such as Tourette syndrome and post-infectious encephalitis.
Treatment
Treatment for PANDAS involves a comprehensive approach that includes both general measures and specific therapeutic interventions. General treatment may include:
- Psychotherapy to support the child's emotional state and overcome OCD and behavioral disorders.
- Educational support to assist with integration into the school environment.
Pharmacological treatment is an important part of therapy and may include:
- Antibacterial drugs to control streptococcal infection.
- Antidepressants and anxiolytics for managing OCD symptoms.
- Corticosteroids to reduce the neuroinflammatory response.
Surgical treatment may be recommended in rare cases where there is a tic that is resistant to therapy or other severe manifestations, but such measures require an individual approach.
Other treatments may include:
- Immunotherapy aimed at modulating autoimmune captivity, such as plasmapheresis.
- Therapy using immunoglobulins.
List of medications used to treat this disease
- Penicillin and its derivatives (amoxicillin).
- Antidepressants (fluoxetine, sertraline).
- Corticosteroids (prednisolone).
- Immunoglobulins.
- Plasmapheresis.
Disease monitoring
Monitoring the condition of children with PANDAS is an important aspect of treatment and involves a number of sequential stages. Monitoring the condition of the child is carried out with regular control visits to the doctor to assess the effectiveness of therapy and the adequacy of the interventions performed. It is important to monitor:
- Symptomatic benefits of treatments and their side effects.
- Changes in behavior and mental health.
The prognosis with proper diagnosis and treatment is generally good, but some children may require long-term treatment and support. Possible complications may include relapses, chronic manifestations of OCD or tic disorder.
Age-related features of the disease
PANDAS may present differently in different age groups. In younger children, the main symptoms are more often play disturbances and behavioral changes, while in adolescents and older children, more pronounced psychopathological manifestations associated with OCD and tics may predominate. It is also important to note that the immune and neurological characteristics of children can influence the course of the disease, which requires that clinicians take an adaptive approach to diagnosis and treatment.
Questions and Answers
- What causes PANDAS? The main cause is an autoimmune reaction to streptococcal infection, which leads to damage to the nervous system.
- What are the main symptoms of the disease? The main symptoms include obsessive-compulsive disorders, tics and behavior changes.
- How is PANDAS diagnosed? Diagnosis is based on clinical manifestations, medical history, laboratory tests for the presence of antibodies to streptococci, and exclusion of other disorders.
- How is PANDAS treated? Treatment involves a multidisciplinary approach using antibiotics, psychotherapy and, in some cases, corticosteroids.
- What is the prognosis for PANDAS? The prognosis is usually good, but long-term treatment and support may be required to prevent relapse.